NUR-FPX6008.assessment2.attempt1.edited (1)
docx
keyboard_arrow_up
School
Capella University *
*We aren’t endorsed by this school
Course
6008
Subject
Health Science
Date
Feb 20, 2024
Type
docx
Pages
8
Uploaded by AdmiralTree10396
1
Needs Analysis for Change
Shelly Durst, BSN, RN
NHS-FPX6008-Economy Decision Making Healthcare
February 14, 2024
2
Summarize Chosen Economic Issue
With the prescription medications cost rising, it has emerged as a significant economic issue within the healthcare system, exerting profound effects on patient care, services offered, and organizational structures and operations. At UPMC WM Hospital, where I work as a nurse, this issue is acutely felt, impacting my ability to provide comprehensive care to patients and the overall dynamics of our healthcare setting. The cost-benefit analysis of prescribing medications becomes increasingly complex as prices escalate, prompting healthcare providers to weigh the financial burden on patients against the potential benefits of specific treatments. The supply and demand dynamics are disrupted, as patients may forego necessary medications due to financial constraints, affecting the quality of care and patient outcomes. Additionally, the rising costs create challenges in maintaining an efficient and sustainable healthcare system, as resources are diverted to accommodate escalating pharmaceutical expenses.
The economic ramifications extend beyond the hospital setting and resonate within the local rural community. Vulnerable populations, already facing socioeconomic disparities, bear the brunt of these escalating medication costs. As a nurse, I witness firsthand the struggles of patients struggling to make difficult choices between purchasing necessary medications and meeting basic needs. The impact on my nursing colleagues is palpable as we collectively navigate the ethical dilemmas of providing equitable care in the face of rising prescription costs. The organizational structure of UPMC WM Hospital is under strain, as financial resources are stretched to accommodate the increasing medication expenses, potentially compromising the overall quality and accessibility of healthcare services.
3
The need for effective regulatory measures and pricing transparency within the pharmaceutical industry becomes evident when examining the root causes of the rising cost of prescription medications. A significant gap exists in the current regulatory framework, allowing pharmaceutical companies to set prices without sufficient oversight. This lack of transparency exacerbates the economic challenges healthcare providers, patients, and communities face. Pursuing solutions to this issue is not only a matter of economic necessity but also aligns with the fundamental principles of healthcare equity and accessibility. Addressing this gap through regulatory reforms and demanding pricing transparency will contribute to a more sustainable and
patient-centered healthcare system, fostering better outcomes for individuals and the rural community (Bush & Sommers, 2022).
Identify Socioeconomic or Diversity Disparities
In addressing the economic challenges associated with the rising cost of prescription medications within the UPMC WM healthcare system, it is imperative to develop ethical and culturally equitable solutions. One approach is to establish a comprehensive medication assistance program that considers the socioeconomic and diversity disparities within the rural community served by UPMC WM. This program should be designed to provide financial assistance to individuals with limited economic means, ensuring that they have access to essential medications without compromising their financial stability.
Understanding the needs of the elderly and low-income populations is crucial in creating targeted interventions. For instance, implementing community outreach initiatives to educate the elderly about cost-effective alternatives and generic medications can empower them to make informed decisions about their healthcare. Additionally, fostering partnerships with pharmaceutical companies to negotiate reduced prices for essential medications can contribute to
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
4
making these drugs more affordable for low-income individuals, thus mitigating the economic burden they face.
To ensure cultural equity, healthcare providers within UPMC WM should engage with community leaders and organizations to gain insights into cultural nuances that may impact medication adherence. Implementing language-accessible materials and providing multilingual support can enhance communication and understanding, reducing barriers to medication compliance. By tailoring solutions to the unique needs and challenges of the diverse population within the rural community, UPMC WM can enhance the quality of care and services offered, fostering a more inclusive and equitable healthcare system.
Explain the Findings of Evidence-Based or Scholarly Sources
Evidence-based research consistently highlights the pressing need to address the escalating costs of prescription drugs, particularly concerning their impact on vulnerable demographics such as the elderly and low-income populations residing in rural areas. A study published in The National Library of Medicine underscores this urgency by elucidating how these groups face significant challenges accessing affordable medication due to various factors, including limited healthcare infrastructure, reduced competition among pharmacies, and higher transportation costs. The research emphasizes that as prescription drug prices continue to soar, rural residents, especially those on fixed incomes, are disproportionately burdened, often forced to forgo necessary medications or sacrifice other essential needs to afford them (Patterson & Carroll, 2020).
Qualitative insights from interviews and focus groups with affected individuals shed light
on the lived experiences and hardships endured because of exorbitant drug prices. Stories of
5
seniors rationing medications or resorting to dangerous alternatives due to financial strain provide poignant anecdotes that underscore the human toll of this issue. Additionally, qualitative data helps uncover nuanced barriers to access, such as stigma around seeking assistance or reluctance to disclose financial struggles (Gupta et al., 2019).
On the quantitative front, robust data analysis unveils the stark economic realities rural communities face. Statistical modeling reveals the correlation between rising drug costs and adverse health outcomes, including increased hospitalizations and poorer treatment adherence. Furthermore, cost-benefit analyses demonstrate the potential savings of implementing policy interventions to curb prescription drug prices, illustrating the compelling economic argument for reform.In pursuit of change, the evidence supports the implementation of comprehensive strategies to mitigate these issues. Policy interventions aimed at price controls, generic drug promotion, and increased accessibility to affordable healthcare services emerge as viable solutions. Collaborative efforts involving policymakers, healthcare providers, and pharmaceutical companies are imperative to ensure a holistic and sustainable approach to addressing the rising cost of prescription drugs (Vincent Rajkumar, 2020).
By integrating qualitative insights and quantitative data, stakeholders and colleagues can be informed comprehensively about the urgency of addressing this issue. The qualitative narratives provide a nuanced understanding of the human impact, while quantitative data quantifies the economic toll, fostering a compelling case for change. This holistic approach equips decision-makers with a robust foundation for informed and evidence-driven economic decision-making to effectively address the challenges posed by escalating prescription drug costs
on the elderly and low-income populations in rural areas.
Explain the Predicted Outcomes and Opportunities for Growth
6
The implementation plan targeting the surge in prescription medications and its impact on
elderly and low-income families in rural areas is poised to yield multifaceted outcomes and growth opportunities. As a result of this strategic initiative, UPMC WM anticipates improving overall health outcomes for the affected demographic, leading to increased community well-
being. Providing accessible and affordable prescription medications will contribute to declining health disparities, fostering a healthier and more resilient population.
Furthermore, this implementation plan will likely create economic opportunities for UPMC WM. By addressing the specific needs of the elderly and low-income families, the healthcare system can tap into new markets and patient populations. This diversification can increase revenue streams and financial stability for UPMC WM, positioning it as a leader in addressing the evolving healthcare landscape.
Regarding ethical considerations, the plan emphasizes cultural equity, ensuring that healthcare services are delivered with sensitivity to the diverse backgrounds of the population. This commitment to cultural competence aligns with ethical principles and promotes inclusivity, enhancing trust and engagement with the community. By incorporating these values into economic strategies, UPMC WM meets ethical standards and builds a foundation for long-term positive relationships with the community.
The implementation plan also addresses dynamic environmental forces, recognizing the ever-changing healthcare landscape. UPMC WM can navigate challenges effectively and maintain its commitment to quality care by remaining adaptable and responsive to external factors. This flexibility enhances the sustainability of the healthcare system, safeguarding its resources for future generations.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
7
Conclusion
In conclusion, the implementation plan tackles the immediate issue of rising prescription medication costs and sets the stage for comprehensive community well-being, economic growth, ethical practices, and environmental resilience. UPMC WM's dedication to these principles ensures a secure future in terms of resources and its ability to provide high-quality care to a diverse and dynamic population.
8
References
Bush, L., & Sommers, B. D. (2022). Improving prescription drug affordability through regulatory action. JAMA Health Forum, 3(8). https://doi.org/10.1001/jamahealthforum.2022.3180
Gupta, S., McColl, M. A., Guilcher, S. J. T., & Smith, K. (2019). Managing medication cost burden: A qualitative study exploring experiences of people with disabilities in Canada. International Journal of Environmental Research and Public Health, 16(17), 3066. https://doi.org/10.3390/ijerph16173066
Patterson, J. A., & Carroll, N. V. (2020). Should the United States government regulate prescription prices? A critical review. Research in Social and Administrative Pharmacy, 16(5), 717–723. https://doi.org/10.1016/j.sapharm.2019.06.010
Vincent Rajkumar, S. (2020). The high cost of prescription drugs: Causes and solutions. Blood Cancer Journal
, 10
(6). https://doi.org/10.1038/s41408-020-0338-x